Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells.
暂无分享,去创建一个
[1] Yan Zhang,et al. lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[2] Y. Zhang,et al. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. , 2017, The Journal of clinical investigation.
[3] Zhonghua Ma,et al. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression , 2017, Cell Death & Disease.
[4] N. Zhong,et al. Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression , 2017, Biology Open.
[5] Bin Liu,et al. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[6] P. Wei,et al. Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma , 2017, Journal of Cancer.
[7] H. Ling,et al. The "good-cop bad-cop" TGF-beta role in breast cancer modulated by non-coding RNAs. , 2017, Biochimica et biophysica acta. General subjects.
[8] Baohong Jiang,et al. Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[9] Feng Xu,et al. Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] K. Rohr,et al. The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells , 2017, Scientific Reports.
[11] Longyang Jin,et al. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] Feng Zhu,et al. Long Noncoding RNA PVT1 Promotes EMT and Cell Proliferation and Migration Through Downregulating p21 in Pancreatic Cancer Cells , 2017, Technology in cancer research & treatment.
[13] W. Wu,et al. lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT. , 2017, European review for medical and pharmacological sciences.
[14] Xiang Yu,et al. Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma , 2017, Cancer medicine.
[15] Z. Zeng,et al. Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma , 2017, Journal of Cancer.
[16] Jun Lu,et al. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer , 2016, Cell Death and Differentiation.
[17] E. Kotteas,et al. Management and Outcomes in Metaplastic Breast Cancer. , 2016, Clinical breast cancer.
[18] D. Yan,et al. Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] Yujie Sun,et al. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK , 2016, Oncotarget.
[20] L. Pusztai,et al. Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer. , 2016, The oncologist.
[21] Maryam Majidinia,et al. Long non-coding RNAs in cancer drug resistance development. , 2016, DNA repair.
[22] Shufeng Zhou,et al. Molecular mechanisms for tumour resistance to chemotherapy , 2016, Clinical and experimental pharmacology & physiology.
[23] B. Leone,et al. Adjuvant systemic therapy in older women with breast cancer , 2016, Breast cancer.
[24] David A Jaffray,et al. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition , 2016, The Lancet.
[25] R. Kong,et al. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer , 2016, Oncotarget.
[26] Zhijin Zhang,et al. LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability and promotes apoptosis of colorectal cancer cells. , 2016, American journal of translational research.
[27] X. Zhi,et al. Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway , 2015, Journal of Experimental & Clinical Cancer Research.
[28] B. Han,et al. The Role of MicroRNAs in the Chemoresistance of Breast Cancer , 2015, Drug development research.
[29] J. Zhao,et al. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer , 2015, Cell cycle.
[30] T. Xia,et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer , 2014, Scientific Reports.
[31] S. Zhong,et al. Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs , 2014, PloS one.
[32] M. Geng,et al. A novel long non-coding RNA-ARA: adriamycin resistance-associated. , 2014, Biochemical pharmacology.
[33] Bangshun He,et al. Analysis of long non-coding RNA expression profiles in gastric cancer. , 2013, World journal of gastroenterology.